Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 8/20 | 0.46 |
| ▸ | AKT1 | P31749 | 7/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | USP7 | Q93009 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | MARK4 | Q96L34 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | NR1I3 | Q14994 | 2/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25789522 | 0.96 | AKT1 (0.43) | AKT2AKT1NPC1RAB9AROCK2 | |
| SCHEMBL24479517 | 0.94 | AKT2 (0.46) | AKT2AKT1NPC1RAB9AADRA1B | |
| SCHEMBL25789391 | 0.93 | AKT2 (0.44) | AKT2AKT1NPC1RAB9AROCK2 | |
| SCHEMBL25789245 | 0.91 | AKT1 (0.43) | AKT2AKT1NPC1RAB9A | |
| SCHEMBL25789399 | 0.91 | AKT1 (0.41) | AKT2AKT1NPC1RAB9AROCK2 | |
| SCHEMBL25789300 | 0.89 | AKT1 (0.39) | AKT2AKT1NPC1RAB9AHSP90AA1 | |
| SCHEMBL24479451 | 0.89 | AKT1 (0.43) | AKT2AKT1NPC1RAB9AADRA1B | |
| SCHEMBL24479093 | 0.88 | AKT1 (0.44) | AKT2AKT1NPC1RAB9AADRA1B | |
| SCHEMBL22673323 | 0.88 | AKT1 (0.43) | AKT2AKT1NPC1RAB9AROCK2 | |
| SCHEMBL25789945 | 0.87 | AKT2 (0.45) | AKT2AKT1NPC1RAB9AROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TELO2, SOD1, TERT | AKT2 3327/4885AKT1 2890/4885NPC1 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.